To include your compound in the COVID-19 Resource Center, submit it here.

Theratechnologies, Merck KGaA sales and marketing update

Theratechnologies said it sent a first shipment of 1 mg Egrifta tesamorelin to its U.S. distributor and that the analog

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE